retatrutide type 2 diabetes phase 2 trial 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending A New Obesity Drug Delivered

Rare but serious effectssuch as pancreatitis or thyroid-related issuesshould be discussed with your provider

The researchers concluded that most of these hormonal changes (particularly TSH and free T3) appeared to be independent of weight loss, suggesting a possible direct effect of semaglutide on thyroid regulation that still needs to be clarified, while changes in free T4 were more closely related to weight change

Despite the limitations, these data suggest that long term therapy is not associated with durable weight loss with withdrawal of the medication and supports guidelines for extended therapy

Week 3-4 and beyond: When things get more sensitive: Once you hit around week 3-4 (thats when youd miss your period and take a test), things change

Open communication helps manage headaches more effectively on GLP-1